AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

7 Drugs in Development

7 Drugs in Development

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

7DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

API REF. PRICE (USD/KG)

$ 0

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Regulatory FDF Prices

API/FDF Prices: Book a Demo to
explore the features and consider
upgrading later

MARKET PLACE

API

FDF

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Btk-in-30, 2662512-15-2, [(2s,5s)-5-[4-amino-5-[4-(2,3-difluorophenoxy)phenyl]imidazo[5,1-f][1,2,4]triazin-7-yl]oxan-2-yl]methanol, [(2s,5s)-5-{4-amino-5-[4-(2,3-difluorophenoxy)phenyl]imidazo[5,1-f][1,2,4]triazin-7-yl}oxan-2-yl]methanol, Birelentinib [inn], Orb2566759

Molecular Formula

C₂₃H₂₁F₂N₅O₃

Molecular Weight

453.4 g/mol

InChI Key

NQJKXHPWHYRGST-ZBFHGGJFSA-N

FDA UNII

Z2F599L9GD

1 2D Structure

Birelentinib

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

[(2S,5S)-5-[4-amino-5-[4-(2,3-difluorophenoxy)phenyl]imidazo[5,1-f][1,2,4]triazin-7-yl]oxan-2-yl]methanol

2.1.2 InChI

InChI=1S/C23H21F2N5O3/c24-17-2-1-3-18(19(17)25)33-15-7-4-13(5-8-15)20-21-22(26)27-12-28-30(21)23(29-20)14-6-9-16(10-31)32-11-14/h1-5,7-8,12,14,16,31H,6,9-11H2,(H2,26,27,28)/t14-,16+/m1/s1

2.1.3 InChI Key

NQJKXHPWHYRGST-ZBFHGGJFSA-N

2.2 Other Identifiers

2.2.1 UNII

Z2F599L9GD

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. Btk-in-30

2. 2662512-15-2

3. [(2s,5s)-5-[4-amino-5-[4-(2,3-difluorophenoxy)phenyl]imidazo[5,1-f][1,2,4]triazin-7-yl]oxan-2-yl]methanol

4. [(2s,5s)-5-{4-amino-5-[4-(2,3-difluorophenoxy)phenyl]imidazo[5,1-f][1,2,4]triazin-7-yl}oxan-2-yl]methanol

5. Birelentinib [inn]

6. Orb2566759

7. Z2f599l9gd

8. Schembl23611096

9. Gtpl13735

10. Dzd8586

11. Dzd-8586

12. Compound 14 [wo2021136219a1]

13. Hy-160167

14. Cs-0925921

15. (2s,5s)-5-[4-amino-5-[4-(2,3-difluorophenoxy)phenyl]imidazo[5,1-f][1,2,4]triazin-7-yl]tetrahydro-2h-pyran-2-methanol

16. 2h-pyran-2-methanol, 5-(4-amino-5-(4-(2,3-difluorophenoxy)phenyl)imidazo(5,1-f)(1,2,4)triazin-7-yl)tetrahydro-, (2s,5s)-

2.4 Create Date

2021-08-21

3 Chemical and Physical Properties

Molecular Formula	C₂₃H₂₁F₂N₅O₃
Molecular Weight	453.4 g/mol
XLogP3	2.6
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	9
Rotatable Bond Count	5
Exact Mass	Da
Monoisotopic Mass	Da
Topological Polar Surface Area	108
Heavy Atom Count	33
Formal Charge	0
Complexity	643
Isotope Atom Count	0
Defined Atom Stereocenter Count	2
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1